G-protein beta-3-subunit and eNOS gene polymorphism in transplant recipients with long-term renal graft function

Kidney Blood Press Res. 2002;25(4):245-9. doi: 10.1159/000066346.

Abstract

Background: Despite new immunosuppressive drugs, only a minority of graft survive over 15 years. The aim of our study was to determine the influence of gene polymorphisms in the G-protein-beta(3) subunit (Gbeta3) and endothelial nitric oxide synthase (eNOS) on the long-term outcome of kidney grafts.

Methods: Using PCR, corresponding genotypes in Gbeta3 (C825T) and eNOS (G894T) gene polymorphism were evaluated in patients with preserved graft function over 15 years and in a control group of transplant recipients.

Results: There were no differences in allele and genotype distributions of both polymorphisms between groups. In Gbeta3 polymorphism, the 825T allele carriers had a significantly lower body mass index while in eNOS polymorphism there were no links between genotypes, renal function and atherosclerosis risk factors.

Conclusions: Our data suggest that these gene polymorphisms have only a minor influence on long-term renal graft function.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Arteriosclerosis / complications
  • Body Mass Index
  • Female
  • Genotype
  • Graft Survival / genetics*
  • Graft Survival / physiology*
  • Heterotrimeric GTP-Binding Proteins / genetics*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Kidney Function Tests
  • Kidney Transplantation / physiology*
  • Male
  • Middle Aged
  • Nitric Oxide Synthase / genetics*
  • Nitric Oxide Synthase Type III
  • Polymorphism, Genetic / genetics*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Risk Factors

Substances

  • G-protein beta3 subunit
  • Immunosuppressive Agents
  • NOS3 protein, human
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type III
  • Heterotrimeric GTP-Binding Proteins